Inobrodib has a broad spectrum of potential applications due to its mechanism of action - strong pre-clinical and clinical data support its use in treating multiple indications.
Potential suitability for enrolment in an inobrodib clinical trial will be made by oncologists at our participating hospitals, and not by CellCentric. Any advice on clinical study options should come from your general practitioner and/or oncologist.